All In Biotech

Drug Trial Radar · NCT03687268

Naloxone HCl PR Tablets in Patients With Opioid Induced Constipation

Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre, Phase III Trial to Investigate the Efficacy, Safety and Tolerability of Naloxone HCl PR Tablets in Patients With Opioid Induced Constipation

Last checked: Nov 20, 2026Latest source record: Sep 28, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 1,500 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

1,500

Planned (sponsor's estimate)

Start

Jul 31, 2017

Primary completion

Nov 2019

Study completion Dec 2019

Sponsor

Lead sponsor
Develco Pharma Schweiz AGIndustry
Sponsor type
Industry
First posted
Sep 27, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective, randomised, double-blind, double-dummy, placebo-controlled, parallel-group, multi-centre, phase III trial of Naloxone HCl PR Tablets (12 mg and 24 mg) administered twice daily. The trial will consist of four phases: Screening phase (Week -4 to Week -3): Confirmation phase (Week -2 to Week -1): Double-blind treatment phase Follow-up phase (Week 13-14):

Conditions

  • Opioid-Induced Constipation

Interventions

  • Naloxone HCl PR tabletsDrug

    oral administration

  • Placebo Oral TabletDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of overall CSBM Responders.Time frame: 12 weeks

Locations

104 sites in 9 countries. Site status is shown where the registry gives one.

  • Plovdiv

    Plovdiv, Bulgaria · Recruiting

  • Sevlievo

    Sevlievo, Bulgaria · Recruiting

  • Sofia

    Sofia, Bulgaria · Recruiting

  • Veliko Tarnovo

    Veliko Tarnovo, Bulgaria · Recruiting

  • České Budějovice

    České Budějovice, Czechia · Recruiting

  • Choceň

    Choceň, Czechia · Recruiting

  • Hradec Králové

    Hradec Králové, Czechia · Recruiting

  • Liberec

    Liberec, Czechia · Recruiting

  • Most

    Most, Czechia · Recruiting

  • Ostrava

    Ostrava, Czechia · Recruiting

  • Plzeň

    Pilsen, Czechia · Recruiting

  • Praha 10

    Prague, Czechia · Recruiting

  • Sokolov

    Sokolov, Czechia · Recruiting

  • Uherské Hradiště

    Uherské Hradiště, Czechia · Recruiting

  • Zlín

    Zlín, Czechia · Recruiting

  • Znojmo

    Znojmo, Czechia · Recruiting

  • Bad Honnef

    Bad Honnef, Germany · Recruiting

  • Bad Pyrmont

    Bad Pyrmont, Germany · Recruiting

  • Berlin

    Berlin, Germany · Recruiting

  • Böhlen

    Böhlen, Germany · Recruiting

  • Bonn

    Bonn, Germany · Recruiting

  • Eichstätt

    Eichstätt, Germany · Recruiting

  • Fellbach

    Fellbach, Germany · Recruiting

  • Göppingen

    Göppingen, Germany · Recruiting

  • Hamburg

    Hamburg, Germany · Recruiting

  • Jahnsdorf

    Jahnsdorf, Germany · Recruiting

  • Kevelaer

    Kevelaer, Germany · Recruiting

  • Marburg

    Marburg, Germany · Recruiting

  • Münster

    Münster, Germany · Recruiting

  • Stadtroda

    Stadtroda, Germany · Recruiting

  • Würzburg

    Würzburg, Germany · Recruiting

  • Bialystok

    Bialystok, Poland · Recruiting

  • Bielsko-Biala

    Bielsko-Biala, Poland · Recruiting

  • Bydgoszcz

    Bydgoszcz, Poland · Recruiting

  • Gdansk

    Gdansk, Poland · Recruiting

  • Katowice

    Katowice, Poland · Recruiting

  • Krakow

    Krakow, Poland · Recruiting

  • Lodz

    Lodz, Poland · Recruiting

  • Ostrowiec Swietokrzyski

    Ostrowiec Świętokrzyski, Poland · Recruiting

  • Rzeszow

    Rzeszów, Poland · Recruiting

Showing 40 of 104 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.